Optimal predictive probability designs for randomized biomarker-guided oncology trials

Emily C. Zabor, Alexander M. Kaizer, Nathan A. Pennell +1

Efforts to develop biomarker-targeted anti-cancer therapies have progressed rapidly in recent years. Six antibodies acting on programmed death ligand 1 or programmed death 1 pathwa…